Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Management of Non-Organic Dysphonia in Adults.

NCT06856785 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-03
Last updated
2025-03-04

Condition(s) studied

Functional DysphoniaResonance Tube Voice TherapySmith Accent Method Therapy

Investigational drug(s) / intervention(s)

Resonance Tube Voice Therapy in Water

Resonance Tube Voice Therapy in Water: Resonance Tube of 28 cm in length and 9 mm diameter for adults will be submerged into a bowl of water .Both flexible soft walled tubes,glass tubes or straws can be used

Study summary

The purpose of this study is to determine the effect of a semi-occluded vocal tract training program, "Resonant Tube Therapy," versus the "Traditional Smith-accent Method" on the quality of voice in patients with Non-Organic "Functional" dysphonia.

Eligibility

Sex
ALL
Min age
15 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients diagnosed with non-organic functional dysphonia with or without Minimally Associated Pathological lesions and referred for voice therapy. The diagnosis was based on the results of the routine clinical assessment of cases of voice disorders by a phoniatrician in the voice clinic. * Patients 'ages between 15 - 60 years old. * Native speakers of Arabic. * Language comprehension adequate for the task. Exclusion Criteria: * Patients with organic voice disorders. * Patients with aphonia or Phon asthenia. * Females within the week of their menstrual cycle or menstruating at the time of data collection to control for the possible hormonal effects or premenstrual water retention on voice quality. * History of severe respiratory allergies, thyroid pathologies, neuro-motor impairment, hearing impairment, psychiatric problems and physically limiting diseases that might interfere with study completion. * Those on any regular medication that might affect voice quality. * Speech disorders. * Cigarette smoking, alcohol, or drug abuse for the past 5 years. * Patients with previous micro laryngeal surgery. * Patients with gastrointestinal reflux disease.

Primary outcome measure(s)

  • Voice quality improvement in functional (non-organic) dysphonia adult patients — 12 weeks following end of the treatment
    Patient evaluation will be conducted before and after the voice therapy sessions for the two groups by Voice Handicap Index (VHI).

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine Sohag University Sohag Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06856785 on ClinicalTrials.gov ↗ ← All trials in Egypt